Bluejay Diagnostics Book Value Per Share Growth & History (BJDX)
Bluejay Diagnostics's book value per share was $9.88 for fiscal 2025.
View full Bluejay Diagnostics company overviewBluejay Diagnostics annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.88 | -$31.48 | −76.11% |
| 2024 | 2024-12-31 | $41.37 | -$3,696.33 | −98.89% |
| 2023 | 2023-12-31 | $3,737.70 | -$14,535.37 | −79.55% |
| 2022 | 2022-12-31 | $18,273.07 | -$14,155.66 | −43.65% |
| 2021 | 2021-12-31 | $32,428.74 | $75,196.13 | — |
| 2020 | 2020-12-31 | -$42,767.39 | — | — |
Bluejay Diagnostics quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $4.75 | -$9.42 | −66.49% |
| Q1 2026 | 2026-03-31 | $4.04 | -$23.87 | −85.52% |
| Q4 2025 | 2025-12-31 | $9.88 | -$31.48 | −76.11% |
| Q3 2025 | 2025-09-30 | $9.01 | -$71.36 | −88.79% |
| Q2 2025 | 2025-06-30 | $14.16 | -$654.64 | −97.88% |
| Q1 2025 | 2025-03-31 | $27.92 | -$1,976.05 | −98.61% |
| Q4 2024 | 2024-12-31 | $41.37 | -$3,696.33 | −98.89% |
| Q3 2024 | 2024-09-30 | $80.38 | -$6,650.94 | −98.81% |
| Q2 2024 | 2024-06-30 | $668.80 | -$9,300.61 | −93.29% |
| Q1 2024 | 2024-03-31 | $2,003.97 | -$12,328.49 | −86.02% |
| Q4 2023 | 2023-12-31 | $3,737.70 | -$14,535.37 | −79.55% |
| Q3 2023 | 2023-09-30 | $6,731.32 | -$15,199.33 | −69.31% |
| Q2 2023 | 2023-06-30 | $9,969.41 | -$16,481.49 | −62.31% |
| Q1 2023 | 2023-03-31 | $14,332.46 | -$15,027.95 | −51.18% |
| Q4 2022 | 2022-12-31 | $18,273.07 | -$14,155.66 | −43.65% |
| Q3 2022 | 2022-09-30 | $21,930.65 | $25,214.18 | — |
| Q2 2022 | 2022-06-30 | $26,450.90 | — | — |
| Q1 2022 | 2022-03-31 | $29,360.41 | — | — |
| Q4 2021 | 2021-12-31 | $32,428.74 | $75,196.13 | — |
| Q3 2021 | 2021-09-30 | -$3,283.52 | — | — |
| Q4 2020 | 2020-12-31 | -$42,767.39 | — | — |
Bluejay Diagnostics book value per share trends
Over the last five fiscal years, Bluejay Diagnostics's book value per share increased from -$42,767.39 to $9.88, a change of $42,777.28. The latest reported quarter, Q2 2026, shows $4.75.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bluejay Diagnostics source filings ↗